Prelude Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $615K | Buy |
+53,069
| New | +$615K | 0.06% | 383 |
|
|
2024
Q2 | – | Sell |
-5,753
| Closed | -$216K | – | 1406 |
|
|
2024
Q1 | $216K | Buy |
+5,753
| New | +$216K | 0.01% | 960 |
|
|
2021
Q4 | – | Sell |
-1,386
| Closed | -$202K | – | 1925 |
|
|
2021
Q3 | $202K | Sell |
1,386
-1,622
| -54% | -$236K | 0.01% | 1031 |
|
|
2021
Q2 | $589K | Buy |
3,008
+642
| +27% | +$126K | 0.02% | 674 |
|
|
2021
Q1 | $428K | Sell |
2,366
-317
| -12% | -$57.3K | 0.01% | 649 |
|
|
2020
Q4 | $380K | Buy |
2,683
+494
| +23% | +$70K | 0.01% | 443 |
|
|
2020
Q3 | $273K | Buy |
2,189
+1,239
| +130% | +$155K | 0.01% | 418 |
|
|
2020
Q2 | $85K | Buy |
+950
| New | +$85K | ﹤0.01% | 694 |
|